secwatch / observer
8-K filed March 22, 2024, 7:59 PM ET ticker GRDX CIK 0001604191
regulatory confidence high sentiment positive materiality 0.60

GridAI Technologies Corp. (GRDX): Nasdaq/NYSE listing notice — Nasdaq issues reprimand to First Wave BioPharma for shareholder approval lapse; matter closed

GridAI Technologies Corp.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.92

GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding shareholders (rules 5635(d)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
shareholders
Rules
5635(d)
Exact text from the filing
March 19, 2024, the Company received a Letter of Reprimand (the “Letter”) from the Staff in accordance with Nasdaq’s Listing Rule 5810(c)(4). The Staff’s determination relates to the offering and issuance by the Company (the “Offering”) of an aggregate of: (i) 610,000 shares (the “Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company, (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 2,675,000 shares of Common Stock (the “Pre-Funded Warrant Shares”) and (iii) common warrants (the “Warrants”) to purchase up to an aggregat
View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

GridAI Technologies Corp. filing history →

Source: SEC EDGAR
accession 0001104659-24-037932
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.